🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06182215
Recruiting Observational

PostoperAtive Neurocognitive Dysfunction After Major AbdomiNal Surgery (PANDAMAN)

NCT06182215 · tracked via the Priya Life Science China tracker
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Observational
Started
2023-12-11
Last updated
2024-06-17

Condition(s) studied

Elective Major Abdominal Surgery

Study summary

Predisposing and precipitating factors for perioperative delirium for the elderly remain elusive. This research will be conducted to determine risk factors of postoperative delirium.

Eligibility

Sex
ALL
Min age
65 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: 1. 65 to 90 years old to receive elective major abdominal surgery (expected operation time over 2 hours); , 2. American society of Aneshesiologists(ASA)physical status I-III; Exclusion Criteria: 1. Mini-Mental State Examination (MMES) score \< 15; 2. Renal failure (requiring dialysis) or liver failure (Child-Pugh score \> 5); 3. Severe impairment due to structural or hypoxic brain injury, more than 2 days in ICU one month before surgery; 4. Underwent major heart, lung or abdominal surgery within 1 year; 5. Positive for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or symptomatic (e.g. fever, cough, loss of taste/smell); 6. The cognitive assessment cannot be completed because the subject is blind, deaf, or unable to communicate in the local language; 7. Long-term follow-up unavailable (homelessness, active psychosis or substance abuse).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Sixth Affiliated Hospital of Sun Yet-set University Guangzhou Guangdong Recruiting

More Sixth Affiliated Hospital, Sun Yat-sen University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06182215 on ClinicalTrials.gov ↗ ← All trials in China